UCLE 54% v1,2M c.139 f30,164M H.17 News: of Nucle

UCLE 54% v1,2M c.139 f30,164M H.17
News: of Nuclear Fusion or the stuff listed below.

Wed Dec 7th, 2022
NewMediaWire8:37 AM
US Nuclear Strategic Partner Pulmostics is Now Conducting Breast Cancer Clinical Trials
GlobeNewswire8:30 AM
US Nuclear Strategic Partner Pulmostics is Now Conducting Breast Cancer Clinical Trials
Wed Nov 30th, 2022
NewMediaWire8:42 AM
US Nuclear Corp. Announces Third Quarter 2022 Results
GlobeNewswire8:30 AM
US Nuclear Corp. Announces Third Quarter 2022 Results
Tue Nov 22nd, 2022
SEC Filings4:38 PM
General form for quarterly reports under Section 13 or 15(d) - Form 10-Q
Tue Nov 15th, 2022
NewMediaWire10:59 AM
Amid Threats of Nuclear war as Russia's Losses Mount US Nuclears Radiation Monitoring and Safety Products are Needed


Read More: https://investorshangout.com/recentnews/UCLE#ixzz7nUQ2KncF

The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.

I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.